Identification of Novel Drug Targets for the Treatment of Diabetic Retinopathy

Vision loss in diabetic retinopathy (DR) is attributable to retinal vascular disorders that result in macular edema and neoangiogenesis. In addition to laser photocoagulation therapy, intraocular injections of antivascular endothelial growth factor drugs have contributed to the treatment of these di...

Descripción completa

Detalles Bibliográficos
Autor principal: Uemura, Akiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753485/
https://www.ncbi.nlm.nih.gov/pubmed/23991398
http://dx.doi.org/10.4093/dmj.2013.37.4.217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753485/
https://www.ncbi.nlm.nih.gov/pubmed/23991398
http://dx.doi.org/10.4093/dmj.2013.37.4.217

Ejemplares similares